Anuradha Poonepalli

Dr Poonepalli is a regulatory consultant for the Therapeutic Products Branch of the Health Products Regulation Group, Health Sciences Authority (HSA), which administers the regulation and pre-market evaluation for drug registration as well as post-approval variations for new drugs and generic drugs in Singapore. She is a graduate of the University of Health Sciences, Andhra Pradesh, India and obtained a PhD in Cancer research from the National University of Singapore (NUS). She started her career in HSA in 2010 as a clinical evaluator with experience in areas which include cancers, vaccines and biosimilars. Prior to joining HSA, she worked at NUS in cancer research and at the A Star, Institute of Molecular Biology on neural stem cell characterisation.